Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: EMU2 who wrote (31140)	6/25/2015 9:58:02 PM
From: superfly	Read Replies (1) \| Respond to of 63285

Bozo; i'm not quite sure what you are trying to say. To put it into PLAIN ENGLISH, I laughed out loud when I read your original post where you acted as if an $8 price per share was just around the corner and a pre-ordained price by the stock-market gods. I'm sure that you and all the other kool-aid drinkers are disappointed that the stock did not run up to the $6 to $8 range In anticipation of the EMAB readout. But hey, big expectations is what this board is all about. I am sooooo happy that EMU2 can afford to lose every penny WHEN Emab fails AND when this stock is trading at $1.50 post readout on its way to bankruptcy. I certainly can too, but I am hedged and prepared for the worst. Nobody has lost a penny underestimating the performance and expectations of this company. S